» Articles » PMID: 33042555

How Do I Keep Myself Safe? Patient Perspectives on Including Reason for Use Information on Prescriptions and Medication Labels: a Qualitative Thematic Analysis

Overview
Date 2020 Oct 12
PMID 33042555
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Abstract:

Background: Medications are crucial for maintaining patient wellness and improving health in modern medicine, but their use comes with risks. Helping patients to understand why they are taking medications is important for patient-centered care and facilitates patient adherence to prescribed medications. One strategy involves enhancing communication between patients, physicians, and pharmacists through the sharing of reason for use (RFU) information or the indication for medications.

Methods: Semi-structured interviews were conducted with 20 patients in Ontario, Canada, to gain perspectives on how patients currently store their medication information and benefits and disadvantages of adding RFU to prescriptions and medication labels. An interview guide was used by the two interviewers, and the interviews were recorded, transcribed, and thematically coded.

Results: The analysis yielded three main themes: patient decision making with RFU, RFU in modern, patient-centered care, and logistical aspects of communicating RFU. The patients that were interviewed expressed the value of having RFU when deciding if a medication was effective or to stop taking the medication. Patients felt comfortable with RFU being added to prescriptions and acknowledged the value in adding RFU to medication labels, helping patients and others identify and distinguish medications. Patients generally expressed interest in having RFU written in lay language and identified strengths and weaknesses of having access to RFU via a website or app.

Conclusions: Patients rated the importance of knowing RFU very highly, identified the value in sharing RFU with pharmacists on prescriptions, and in having RFU on medication labels. These results can be used to inform policy on the addition of RFU on prescriptions and medication labels and support improved communication between patients, pharmacists, and physicians about RFU.

Citing Articles

Incorporating 'reason for use' into the prescribing process of medication: a survey on the opinion of patients in Flanders, Belgium.

Peeters M, Iturrospe E, Jans D, van Nuijs A, De Loof H BMC Health Serv Res. 2022; 22(1):1216.

PMID: 36180847 PMC: 9523178. DOI: 10.1186/s12913-022-08596-w.


Prescribers' perspectives on including reason for use information on prescriptions and medication labels: a qualitative thematic analysis.

Whaley C, Bancsi A, Ho J, Burns C, Grindrod K BMC Health Serv Res. 2021; 21(1):89.

PMID: 33499869 PMC: 7836591. DOI: 10.1186/s12913-021-06103-1.

References
1.
Shrank W, Avorn J . Educating patients about their medications: the potential and limitations of written drug information. Health Aff (Millwood). 2007; 26(3):731-40. DOI: 10.1377/hlthaff.26.3.731. View

2.
Kobue B, Moch S, Watermeyer J . "It's so hard taking pills when you don't know what they're for": a qualitative study of patients' medicine taking behaviours and conceptualisation of medicines in the context of rheumatoid arthritis. BMC Health Serv Res. 2017; 17(1):303. PMC: 5405531. DOI: 10.1186/s12913-017-2246-8. View

3.
Garabedian P, Wright A, Newbury I, Volk L, Salazar A, Amato M . Comparison of a Prototype for Indications-Based Prescribing With 2 Commercial Prescribing Systems. JAMA Netw Open. 2019; 2(3):e191514. PMC: 6450312. DOI: 10.1001/jamanetworkopen.2019.1514. View

4.
Wolf M, Davis T, Curtis L, Bailey S, Knox J, Bergeron A . A Patient-Centered Prescription Drug Label to Promote Appropriate Medication Use and Adherence. J Gen Intern Med. 2016; 31(12):1482-1489. PMC: 5130952. DOI: 10.1007/s11606-016-3816-x. View

5.
Kennedy A, Littenberg B, Callas P, Carney J . Evaluation of a modified prescription form to address prescribing errors. Am J Health Syst Pharm. 2011; 68(2):151-7. DOI: 10.2146/ajhp100063. View